Historic Accounts Payables for Nuvation Bio (NUVB) over the last 4 years, with Jun 2025 value amounting to $22.4 million.
- Nuvation Bio's Accounts Payables rose 330.22% to $22.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $22.4 million, marking a year-over-year increase of 330.22%. This contributed to the annual value of $6.3 million for FY2024, which is 187.37% up from last year.
- As of Q2 2025, Nuvation Bio's Accounts Payables stood at $22.4 million, which was up 112.76% from $10.5 million recorded in Q1 2025.
- Nuvation Bio's 5-year Accounts Payables high stood at $22.4 million for Q2 2025, and its period low was $2.4 million during Q3 2023.
- Over the past 3 years, Nuvation Bio's median Accounts Payables value was $4.1 million (recorded in 2023), while the average stood at $7.6 million.
- In the last 5 years, Nuvation Bio's Accounts Payables spiked by 694.27% in 2021 and then tumbled by 79.75% in 2023.
- Quarterly analysis of 5 years shows Nuvation Bio's Accounts Payables stood at $5.2 million in 2021, then slumped by 41.99% to $3.0 million in 2022, then dropped by 20.77% to $2.4 million in 2023, then spiked by 421.70% to $12.4 million in 2024, then surged by 330.22% to $22.4 million in 2025.
- Its last three reported values are $22.4 million in Q2 2025, $10.5 million for Q1 2025, and $12.4 million during Q3 2024.
